Cargando…
Prognostic Model of Baseline Medications plus Neutrophil-to-lymphocyte Ratio in Patients with Advanced Non-small-cell Lung Cancer Receiving Immune Checkpoint Inhibitor plus Platinum Doublet: A Multicenter Retrospective Study
Background: Association between baseline medications plus neutrophil-to-lymphocyte ratio (NLR) and the effectiveness of immune checkpoint inhibitor (ICI) plus platinum doublet remains unknown, despite several reported prognostic models. We used real-world data to investigate whether baseline medicat...
Autores principales: | Nasu, Izumi, Kondo, Masahiro, Uozumi, Ryuji, Takada, Shinya, Nawata, Shuichi, Iihara, Hirotoshi, Okumura, Yohei, Takemoto, Masashi, Mino, Kozo, Sasaki, Tadanori, Hirose, Chiemi, Aomori, Tohru, Shimano, Rena, Maeno, Ken, Oizumi, Satoshi, Kusumoto, Sojiro, Ohno, Yasushi, Ikemura, Shinnosuke, Takai, Daiya, Hara, Azusa, Kawazoe, Hitoshi, Nakamura, Tomonori |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10088894/ https://www.ncbi.nlm.nih.gov/pubmed/37056385 http://dx.doi.org/10.7150/jca.80517 |
Ejemplares similares
-
Low‐Dose Olanzapine Plus Granisetron and Dexamethasone for Carboplatin‐Induced Nausea and Vomiting in Patients with Thoracic Malignancies: A Prospective Multicenter Phase II Trial
por: Sakai, Chizuru, et al.
Publicado: (2021) -
Peripheral blood biomarkers predict immune-related adverse events in non-small cell lung cancer patients treated with pembrolizumab: a multicenter retrospective study
por: Egami, Saeka, et al.
Publicado: (2021) -
Absolute Lymphocyte Count Predicts Immune-Related Adverse Events in Patients With Non-Small-Cell Lung Cancer Treated With Nivolumab Monotherapy: A Multicenter Retrospective Study
por: Egami, Saeka, et al.
Publicado: (2021) -
5HT(3)RA plus dexamethasone plus aprepitant for controlling delayed chemotherapy‐induced nausea and vomiting in colorectal cancer
por: Hayashi, Toshinobu, et al.
Publicado: (2020) -
Chemotherapy-induced nausea and vomiting (CINV) with carboplatin plus pemetrexed or carboplatin plus paclitaxel in patients with lung cancer: a propensity score-matched analysis
por: Hayashi, Toshinobu, et al.
Publicado: (2021)